Settlement Amount:
$39,000,000
A settlement has been reached to resolve False Claims Act allegations against Endo International Plc.
The allegations arose from a lawsuit, brought forward by a whistleblower claiming the generic drug maker Qualitest, owned by Endo International Plc, illegally labeled multivitamins that contained fluoride.
New York Attorney General disclosed that Qualitest's false labeling caused healthcare professionals to submit false reimbursement claims to Medicaid and federal health care plans and that it also put patients in higher risk of cavities.
The multivitamins contained only half of the fluoride amount recommended by the United States Food and Drug Administration.
